The objective of this symposium is to provide participants with an understanding of the current diagnostic and treatment trends in malignant glioma, focusing on tumor biology as it applies to treatment.
We will begin this symposium by focusing on the origins and behavior of glial tumors, gaining perspective from an epidemiologist, a cancer biologist and a neuropathologist. Following a break, we will enter the brain and brain tumors through neuro-imaging, focusing on the application of current and evolving technologies to our understanding of tumor diagnosis and response to therapies.
The second half of the symposium will focus on specific aspects of glioma therapy with attention to both tumor grade and histology. A review of current standards of care will be followed by a discussion of evolving technologies and approaches to treatment.
Ample time will be given for discussion between faculty and symposium attendees throughout the day. At the conclusion of this symposium, attendees should have a comprehensive understanding of the current diagnostic and treatment paradigms for malignant gliomas of all types. Furthermore, the insight gained about glioma biology will prepare participants to better understand and appreciate clinical data as it emerges in the new decade.
After attending this educational activity, participants will be able to:
• Appreciate an up-to-date understanding of malignant glioma: its causes and biology;
• Apply this understanding to recent developments in diagnosis, including molecular
pathology and advanced imaging techniques;
• Understand current and evolving treatment paradigms for malignant glioma, focusing on
multi-modality and emerging therapies.
Please join us for what promises to be an informative and thought-provoking symposium.
Registration online at cme.uchicago.edu
Contact information: Maggie Ford, 773-834-0685 or email@example.com
Nurses & Other Health Professionals $40
Residents/Fellows (with letter of verification) $40